sharecast

{{ storiesRelated.title }}

Aim Bulletin
02 Jan
Sareum shares jump on cancer drug licensing deal

Shares in AIM-listed biotech group Sareum jumped by a fifth on Tuesday after its co-development partner for cancer treatment SRA737 signed a commercialisation licence agreement with a US biopharma company.

02 Jan
dl r&q insurance holdings ltd aim rq r and q randall and quilter randall quilter financials insurance non life insurance reinsurance logo
R&Q confirms retirement of founder Alan Quilter

R&Q Insurance Holdings announced the retirement of Alan Quilter, its group head of programme management, on Tuesday.

02 Jan
dl caledonia mining corporation plc aim basic materials basic resources precious metals and mining gold mining logo 20230106
Caledonia Mining declares quarterly dividend

Caledonia Mining declared a quarterly dividend of 14 US cents per share on Tuesday.

02 Jan
dl plexus holdings plc aim energy oil gas and coal oil equipment and services logo 20230301
Plexus inks new agreement with Schlumberger

Oil and gas engineering services company Plexus announced an agreement with Schlumberger (SLB) on Tuesday, superseding a prior surface production wellhead licence and replacing it with a broader arrangement.

02 Jan
dl uru metals aim platinum nickel gold exploration zeb logo
URU pushes repayment date on Boothbay convertible loan

URU Metals has extended the repayment date for its convertible loan from Boothbay Absolute Return Strategies, it announced on Tuesday, to 28 February.

02 Jan
dl plant health care plc london aim phc basic materials chemicals fertilizers fertilisers logo 20230112
Plant Health Care nematicide gets approval in Brazil

Crop peptide specialist Plant Health Care announced on Tuesday that its nematicide product TEIKKO has received federal approval in Brazil, ahead of a commercial launch for the upcoming 2025 soybean growing season.

02 Jan
dl proteome sciences aim science scientific services provider logo
Proteome launches San Diego lab operations

Proteomics services provider Proteome Sciences announced the installation and start of operations at its new laboratory in San Diego, California, on Tuesday.

02 Jan
dl genedrive aim gene drive diagnostics technology logo
Genedrive confirms £0.6m equity prepayment drawdown

Genedrive confirmed a planned £0. 6m drawdown as part of its £5m equity prepayment facility on Tuesday, which it initially disclosed on 31 March 2023.

02 Jan
dl zanaga iron ore company limited aim basic materials basic resources industrial metals and mining iron and steel
Zanaga extends repayment data on Glencore loan

Zanaga Iron Ore Company announced on Tuesday that it has agreed with Glencore to extend the repayment date of its loan facility.

02 Jan
dl maxcyte inc aim health care healthcare pharmaceuticals and biotechnology logo 20230307
Maher Masoud starts as MaxCyte president, CEO

MaxCyte confirmed the appointment of Maher Masoud as its new president and chief executive officer on Tuesday, effective from 1 January.

02 Jan
dl novacyt group aim medical testing diagnostics laboratory coronavirus covid 19 logo
Novacyt taps Steve Gibson for CFO

Biotechnology group Novacyt has appointed Steve Gibson to the role of chief financial officer with immediate effect.

02 Jan
dl angle aim parsortix medical biopsy technology developer healthcare medicine logo
Angle locks in $250,000 contract with Eisai

Liquid biopsy company Angle has locked in a $250,000 contract with global pharmaceutical company Eisai to deliver circulating tumour cell analysis in a pilot study.

02 Jan
dl hvivo plc aim health care healthcare health care providers health care services logo 20230316
hVIVO secures £6.3m contract with biotech client

Infectious and respiratory disease study group hVIVO has inked a £6. 3m contract with an unnamed biotechnology client to test an antiviral candidate using its common cold virus human challenge study model.